1. Incidence of type 2 diabetes and associated factors in the adult population of the Community of Madrid. PREDIMERC cohort
- Author
-
M.D. Esteban-Vasallo, M.D. Martín-Ríos, B. Zorrilla-Torras, A. López-de-Andrés, E. Gil-Montalbán, H. Ortiz-Marrón, and M. Martínez-Cortés
- Subjects
Gerontology ,education.field_of_study ,medicine.medical_specialty ,business.industry ,Incidence (epidemiology) ,Population ,General Medicine ,Type 2 diabetes ,medicine.disease ,Diabetes mellitus ,Internal medicine ,Cohort ,medicine ,Prediabetes ,education ,business ,Prospective cohort study ,Body mass index - Abstract
Objectives Determine the incidence and risk factors of type 2 diabetes in the adult population of Madrid (Spain) and compare the predictive models of type 2 diabetes based on the prediabetes criteria of the American Diabetes Association (ADA) and the World Health Organisation (WHO). Material and methods A prospective study was conducted on a population cohort composed of 2048 individuals between 30 and 74 years of age with no diabetes. At the start of the study, an epidemiological survey was performed, and baseline glycaemia, HbA1c, body mass index and waist circumference were measured. A follow-up of 6.4 years was conducted. New cases of type 2 diabetes were identified using the electronic primary care medical history. Results The incidence of type 2 diabetes was 3.5 cases/1000 person-years. In the multivariate analysis, the variables that were associated with the onset of type 2 diabetes were age, family history of diabetes, baseline glycaemia (100–125 mg/dL), HbA1c (5.7–6.4%) and waist circumference (≥94 cm for men and ≥80 cm for women). Of these, the most significantly associated variables were baseline glycaemia and HbA1c. The ADA and WHO criteria for defining prediabetes had the same predictive capacity. Conclusion The incidence of type 2 diabetes measured in Madrid was lower than that found in other population studies, with the glucometabolic state the main factor associated with progression to type 2 diabetes. There were no differences between the prediabetes defined by the ADA and the WHO for predicting the onset of the disease.
- Published
- 2015